Objective: Squamous cell carcinoma (SCC) is the most common lip carcinoma and nodal status is the single most important prognostic factor. Though surgery is the first choice of treatment in early-stage cases, elective neck dissection to treat an eventual occult metastasis is still a matter of discussion.
INTRODUCTION
Lower lip carcinoma is the most common form of lip cancer (80%) and represents approximately 30% of all oral carcinomas. [1, 2] Most cases of lower lip cancer are cutaneous squamous cell carcinoma (cSCC), the second-most frequently diagnosed malignant skin cancer after basal cell carcinoma. [3] Though there are many risk factors, including older age, male gender, human papilloma virus, immunosuppression, fair skin, or tobacco smoking, the most important risk factor is cumulative ultraviolet exposure. [4] Lower lip SCC spreads first to the submandibular or submental lymph nodes. [5, 6] Though surgical resection is the current treatment of choice for early stage lower lip SCC, the practice of elective lymph node dissection in high-risk patients or cases classified clinically as N0 according to the American Joint Committee on Cancer (AJCC) staging system with no locally advanced disease is still a controversial subject. [7] Some authors consider the practice of elective lymph node dissection in clinically determined N0 cases complementary and necessary, [6, 8] while others consider the practice of neck dissection in patients who have no clinical (physical examination, radiological evaluation) evidence of a pathological lymph node to be excessive. [9, 10] In this context, patients operated on in a single clinic between January 2005 and July 2017 with a lower lip SCC diagnosis were analyzed retrospectively and an analysis was performed to evaluate the approach to lower lip SCC, neck dissection indications, and the contribution of neck dissection to the relative survival rate.
MATERIAL AND METHODS
In this study, the data of 96 lower lip SCC patients who were admitted to the clinic and followed-up between January 2005 and July 2017 were analyzed. The patients were classified according to age, gender, tumor size, pathological type, and the type of neck dissection. The study was conducted according to the principles of the Helsinki Declaration. Patients who were referred to the clinic after primary tumor excision, wide excision, or local recurrence were not included in this study. The diagnoses of patients included in this study were confirmed with a preoperative punch or incisional biopsy. The patients were staged according to the AJCC staging system. [11] Regional or distant metastasis status was evaluated with ultrasound imaging, computed tomography (CT), or positron emission tomography-CT scan, according to the tumor stage.
Approach to lymph nodes
A wedge excision was performed followed by a primary repair when the defect size was less than one-third of the lower lip. The surgical resection was followed by a one-sided or bilateral local flap reconstruction for defects beyond one-third of the lower lip. In cases where a freetissue transfer was required, the defect was temporarily closed and the reconstruction was postponed until safe margins were confirmed with a pathology report. Defect reconstruction will not be detailed in this article. Supraomohyoid neck dissection (SOHLND; lymphadenectomy of level I-II-III lymph nodes) was performed in clinically or radiologically determined lymph node-negative T1 and T2 stage patients if the invasion depth was >2 mm, in immunosuppressed patients, in cases of a poorly differentiated tumor, and in cases with perineural invasion. SOHLND was performed simultaneously in T3-4N0 cases. The dissection was performed bilaterally in cases when the tumor was centrally located. A functional (or type 3 modified-radical) neck dissection, a lymphadenectomy of level I through V lymph nodes sparing the sternocleidomastoid muscle (SCM), internal jugular vein (IJV), and spinal accessory nerve (CN XI) or a modified-radical neck dissection (MRND), a lymphadenectomy of level I through V lymph nodes sparing either 1, 2, or all of the following structures: SCM, IJV, CN XI was performed. In clinically positive cervical lymph node cases, a functional dissection or MRDN was preferred. Patients with a pathology report of metastasis in the neck dissection material were referred to the radiation oncology department due to the potential need for adjuvant radiotherapy. Patients were followed-up every 3 months for 2 years and then every 6 months the following year and annually after the fourth year.
RESULTS
Of the 96 patients in this study, 82 were male (85%) and 14 were female (15%). The youngest patient was 22 years old and the oldest was 87 years of age; the mean age was 59.4 years. The mean length of the follow-up period was 68 months, with a range of 12 to 129 months. In total, an elective (supraomohyoid) neck dissection was performed on 51 of the 96 patients (Table 1) . A metastasis was detected in the pathology material of 23 patients in this group.
A total of 74 patients with T1-2N0 staging were clinically and radiologically node-negative. However, we performed supraomohyoid or functional neck dissection to 30 cases due to the presence of 1 or more high-risk factors. These high-risk factors are summarized in Table 2 . Among these 30 patients, a lymph node metastasis was detected in 6 cases (6% in total, 20% of patients undergoing neck dissection). Analysis of the patients with a positive lymph node finding after dissection revealed that 5 patients of 6 had 2 or more high-risk factors, and 1 patient had only 1 high-risk factor (poorly differentiated). Among the 57 T1 stage (tumor size <2 cm) patients, independent of N stage, 22 had a neck dissection and 10 were diagnosed with metastasis (17.5%). Among all of the T2 stage patients (tumor size >2 cm, or any size with more than 2 high-risk factors), a total of 30 patients, 21 had a neck dissection and 9 were diagnosed with metastasis (30%). Six of 7 T3 stage patients had a neck dissection. One patient did not elect to have the dissection and was referred to the radiation oncology department. Among the 6 neck dissection patients, 3 were diagnosed with lymph node metastasis (50%). A MRND was performed for 2 stage T4 patients. The pathology department reported lymph node metastasis in both biopsies (100%). In a mean follow-up period of 5.5 years, regional metastatic lymph node recurrence was observed in 2 patients of 96 (approximately 2%). A retrospective examination of these 2 cases with recurrence revealed that 1 patient was at T2N0 stage with 1 high-risk factor and clinically and radiologically negative lymph node status and had a SOHLND at the time of excision. The recurrence appeared at the postoperative third year. The other patient was at T2N0 stage with 2 high-risk factors and was advised to have a neck dissection after wide tumor excision but the patient did not give consent. Strict follow-up was performed and recurrence occurred 2 ½ years after the operation.
A metastasectomy was performed for patients according to the decision of the multidisciplinary tumor council of the hospital. Patients who had a positive metastatic lymph node(s) in their supraomohyoid neck dissection pathology material underwent a complementary MRND, if possible. Those who had positive metastatic lymph node(s) in their functional or MRND pathology material were referred to the radiation oncology department.
A wedge excision followed by a primary closure was performed for 41 patients among 96. The resections were full-thickness with a minimum safe margin of 0.5 cm for T1 cases and with a minimum safe margin of 1 cm for T2-3-4 cases.
DISCUSSION
Lower lip SCC is known to have a relatively good prognosis; however, it is also known that lower lip SCC cases may be more invasive and metastatic compared with other head and neck cutaneous SCC cases. [12] Lymph node metastasis in lower lip carcinomas, which are often diagnosed early due to their anatomical localization, considerably lowers the survival rate (approximately 50%), according to many authors. [6] There is a consensus on the necessity of functional (Bocca) neck dissection or MRND to treat level I-V nodes in clinically positive cases independent of T stage, as is suggested by the National Comprehensive Cancer Network guidelines. [13] However, that is not true for clinically negative N0 cases. The results of 1 study that suggested elective supraomohyoid neck dissection in these cases found an approximate rate of occult metastasis of 20%. [6] We calculated a rate of 6% in our study.
Ciloglu et al. [14] did not suggest elective lymph node dissection in Grade I, clinically negative tumors. In our study, neck dissection was performed independent of the N stage in 22 of 57 T1 staged patients and 10 were diagnosed with metastasis. Neck dissection should be kept in mind in high-risk T1 tumors.
The common understanding concerning elective neck dissection in head and neck cancers is that there is a 15% to 20% rate of regional metastasis. [15] [16] [17] Califano et al. [18] argue that capsule rupture and tumor size are the most important parameters regarding the development of cervical metastasis. It is known that tumors surrounded by a large lymphocyte band and well-differentiated carcinomas develop less cervical metastasis. [16, 19] The other high risk SCC characteristics determined by the AJCC are tumor depth (2 mm and beyond), perineural invasion, and immunosuppression. [11, 20] It has been shown that lesions in this high-risk group tend to develop more recurrence and metastasis. Supraomohyoid neck dissection has less comorbidity than MRND aesthetically and functionally. The main reasons are the preservation of neck volume and the functionality of shoulder. [21] It has been reported that 5% to 15% of N0 lower lip SCC patients treated only with primary tumor resection have developed late cervical metastasis. [22, 23] In a study by Koc et al., [24] prophylactic neck dissection was performed for all patients without lymph node metastasis. They concluded that supraomohyoid lymph node dissection should be performed for N0 tumors to decrease the risk of neck node metastasis.
In the literature, there is no consensus concerning the approach to be used for a clinically negative neck node in patients with early grade lip tumors and the reported incidence of neck node metastases has ranged from 0% to 15% for T1 tumors and 11% to 35% for T2 tumors. [25] Occult metastasis in the early stage is often the reason for late cervical metastasis in these cases. As De Visscher et al. [26] and Hosal et al. [27] confirmed that the existence of late cervical metastasis is very resistant to treatment and results mostly in the patient's death in a 1-year period. Though sentinel lymph node biopsy (SLNB) is currently a standard therapy in staging breast cancer and malignant melanoma, this is not the case for head and neck SCC. The potential benefit of SLNB in lower lip SCC cases is being researched in many centers. Sensitivity and negative predictive values have been compared in the use of metastasis detection, and it has been found that SLNB is more predictive than radiological studies but less predictive than selective lymph node dissection. [28] [29] [30] [31] 
CONCLUSION
The results of this study demonstrated that lower lip SCC has a good prognosis among other head and neck cancers with early surgical treatment; however, late cervical metastasis is far from negligible and decreases the survival rate considerably. Therefore, our results support the necessity of performing elective supraomohyoid neck dissection in selected N0T1-2 lower lip SCC cases due to the risk for recurrence and metastasis. It is also evident that SLNB, which is an effective and less comorbid way to assess lymph node status, could be a good option for patients who do not accept a selective neck dissection.
Based on the results of this study, the presence of a highrisk factor is one of the important parameters that should inform the decision about performing lymph node dissection with early stage lower lip carcinoma cases. We advocate at least a prophylactic SOHLND in patients who have high-risk factor(s) with cSCC of the lower lip with a clinically N0 neck and we advocate a SOHLND or functional/MR lymph node dissection for clinically N-positive necks, according to the T stage and number of high-risk factors.
Ethics Committee Approval
Retrospective study.
Peer-review
Internally peer-reviewed. 
Authorship Contributions

